Active	Status	Sponsor type	Region	Phase	Filter
12 Active 5 Inactive 17 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

12 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Walker, Craig M
VERITAS, NCT05312970: Varithena Versus Endothermal Ablation of the Great Saphenous Vein	Terminated	4	43	US	Varithena®, FDA-approved Endothermal Ablation (ETA) systems	Boston Scientific Corporation	Varicose Veins	04/24	04/24
VICTORION-2P, NCT05030428: Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease	Active, not recruiting	3	17004	Europe, Canada, Japan, US, RoW	Inclisiran sodium 300 mg, Placebo	Novartis Pharmaceuticals	Atherosclerotic Cardiovascular Disease	10/27	10/27
STAND, NCT04025008: A Clinical Evaluation of the MicroSTent® PeripherAl Vascular SteNt in Subjects With Arterial Disease Below the Knee	Not yet recruiting	N/A	177	US	MicroStent or percutaneous transluminal angioplasty (PTA)	Micro Medical Solution, Inc.	Peripheral Arterial Disease	01/21	08/21
RESTOR-1, NCT04663867: AngioSafe Peripheral CTO Crossing System Study ( Study)	Completed	N/A	133	US	AngioSafe Peripheral CTO Crossing System	AngioSafe, Inc., Veranex, Inc.	Peripheral Artery Occlusion, Peripheral Arterial Disease	04/23	06/23
NCT03477604: A Clinical Evaluation of the MicroSTent® PeripherAl Vascular SteNt in Subjects with Arterial Disease Below the Knee (STAND)	Active, not recruiting	N/A	177	US	MicroStent and Standard PTA, Standard PTA	Micro Medical Solution, Inc.	Peripheral Arterial Disease	12/23	12/26
NCT05055297: SELUTION4BTK Trial	Recruiting	N/A	376	Europe, US, RoW	SELUTION SLR™ DEB 014, Plain (Uncoated) Balloon Angioplasty (PTA)	MedAlliance, LLC, NAMSA, Cordis Corporation	Peripheral Arterial Disease, Chronic Limb-Threatening Ischemia Nos of Native Arteries of Extremities	06/27	07/29
NCT04280029: SELUTION SLR™ 014 In-stent Restenosis	Active, not recruiting	N/A	418	Europe, Canada, US, RoW	SELUTION SLR™ DEB, Control	M.A. Med Alliance S.A., Iqvia Pty Ltd, Cordis Corporation	Coronary Restenosis	07/25	08/29
GREAT, NCT06321575: The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy ( Trial)	Recruiting	N/A	159	US	Golazo® Peripheral Atherectomy System (Golazo® Peripheral AS)	Avantec Vascular, Bright Research Partners, Yale Cardiovascular Research Group	Peripheral Arterial Disease	11/26	11/26
NCT06492733: FastWire REvascularisation of Extremities, (For LOWer Limbs) - FREEFLOW	Recruiting	N/A	65	US	FastWire System - Peripheral	Versono Medical Ltd	Chronic Total Occlusion of Artery of the Extremities	01/25	02/25
NCT05132361: SELUTION4SFA Trial	Recruiting	N/A	300	Europe, US, RoW	SELUTION SLR™ 018 DEB, Plain (Uncoated) Balloon Angioplasty (PTA)	MedAlliance, LLC, NAMSA, Cordis Corporation	Peripheral Arterial Disease, Superficial Femoral Artery Stenosis	08/25	12/29
THOR, NCT05916950: The IDE Study	Recruiting	N/A	155	US	Thor laser atherectomy, Thor calcium modification	Philips Clinical & Medical Affairs Global, NAMSA, Massachusetts General Hospital	Peripheral Artery Disease, Peripheral Artery Stenosis, Peripheral Artery Calcification, PAD	10/26	11/27
NCT05147363: Shockwave: Disruption for A Better Fit	Recruiting	N/A	50	US	Shockwave Intravenous lithotripsy with a Supera stent	Cardiovascular Institute of the South Clinical Research Corporation, Shockwave Medical, Inc.	Peripheral Arterial Disease	06/22	12/22